Infantile Spasms Autism-Related Disorders

Anavex Announces Positive Preclinical Results with ANAVEX 2-73 in Fragile X – Autism-Related Disorders

Anavex Announces U.S. FDA Orphan Drug Designation to ANAVEX 2-73 for the Treatment of Rett Syndrome

Anavex Announces Positive Preclinical Data for ANAVEX 2-73 in Infantile Spasms